Merck immunotherapy drug shows promise in bladder cancer

MADRID (Reuters) - Merck & Co's new immune system drug Keytruda has produced encouraging results in early tests against bladder cancer, according to a company-sponsored study, prompting the firm to prepare a clinical trial later this year. Keytruda is the first in a new wave of immune-boosting medicines to be approved for treating melanomas in the United States, but it also has potential in a range of other cancers. ...



via Health News Headlines - Yahoo News http://ift.tt/YAHv8A